Terms: = Kidney tumors AND CCDC6, D10S170, 8030, ENSG00000108091, Q16204, TPC, H4, TST1 AND Treatment
16 results:
1. B7-H4 Immune Checkpoint Protein Affects Viability and Targeted Therapy of Renal Cancer Cells.
Emaldi M; Nunes-Xavier CE
Cells; 2022 Apr; 11(9):. PubMed ID: 35563753
[TBL] [Abstract] [Full Text] [Related]
2. Galectin-9 expression as a poor prognostic factor in patients with renal cell carcinoma.
Jikuya R; Kishida T; Sakaguchi M; Yokose T; Yasui M; Hashizume A; Tatenuma T; Mizuno N; Muraoka K; Umemoto S; Kawai M; Yoshihara M; Nakamura Y; Miyagi Y; Sasada T
Cancer Immunol Immunother; 2020 Oct; 69(10):2041-2051. PubMed ID: 32424467
[TBL] [Abstract] [Full Text] [Related]
3. High doses of hydroxytyrosol induce apoptosis in papillary and follicular thyroid cancer cells.
Toteda G; Lupinacci S; Vizza D; Bonofiglio R; Perri E; Bonofiglio M; Lofaro D; La Russa A; Leone F; Gigliotti P; Cifarelli RA; Perri A
J Endocrinol Invest; 2017 Feb; 40(2):153-162. PubMed ID: 27592355
[TBL] [Abstract] [Full Text] [Related]
4. Higher preoperative serum levels of PD-L1 and B7-H4 are associated with invasive and metastatic potential and predictable for poor response to VEGF-targeted therapy and unfavorable prognosis of renal cell carcinoma.
Fukuda T; Kamai T; Masuda A; Nukui A; Abe H; Arai K; Yoshida K
Cancer Med; 2016 Aug; 5(8):1810-20. PubMed ID: 27292320
[TBL] [Abstract] [Full Text] [Related]
5. [Sunitinib inhibits the expressions of co-stimulatory molecule ligands on dendritic cells].
Ding C; Mai H; Chen L; Zhang B
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Apr; 32(4):437-41. PubMed ID: 27053605
[TBL] [Abstract] [Full Text] [Related]
6. Inhibition of nucleoporin member Nup214 expression by miR-133b perturbs mitotic timing and leads to cell death.
Bhattacharjya S; Roy KS; Ganguly A; Sarkar S; Panda CK; Bhattacharyya D; Bhattacharyya NP; Roychoudhury S
Mol Cancer; 2015 Feb; 14():42. PubMed ID: 25743594
[TBL] [Abstract] [Full Text] [Related]
7. Synergistic effects of IL-4 and TNFα on the induction of B7-H1 in renal cell carcinoma cells inhibiting allogeneic T cell proliferation.
Quandt D; Jasinski-Bergner S; Müller U; Schulze B; Seliger B
J Transl Med; 2014 May; 12():151. PubMed ID: 24885059
[TBL] [Abstract] [Full Text] [Related]
8. Secreted frizzled-related protein-5 is epigenetically downregulated and functions as a tumor suppressor in kidney cancer.
Kawakami K; Yamamura S; Hirata H; Ueno K; Saini S; Majid S; Tanaka Y; Kawamoto K; Enokida H; Nakagawa M; Dahiya R
Int J Cancer; 2011 Feb; 128(3):541-50. PubMed ID: 20340127
[TBL] [Abstract] [Full Text] [Related]
9. Wnt antagonist gene DKK2 is epigenetically silenced and inhibits renal cancer progression through apoptotic and cell cycle pathways.
Hirata H; Hinoda Y; Nakajima K; Kawamoto K; Kikuno N; Kawakami K; Yamamura S; Ueno K; Majid S; Saini S; Ishii N; Dahiya R
Clin Cancer Res; 2009 Sep; 15(18):5678-87. PubMed ID: 19755393
[TBL] [Abstract] [Full Text] [Related]
10. Imprinted CDKN1C is a tumor suppressor in rhabdoid tumor and activated by restoration of SMARCB1 and histone deacetylase inhibitors.
Algar EM; Muscat A; Dagar V; Rickert C; Chow CW; Biegel JA; Ekert PG; Saffery R; Craig J; Johnstone RW; Ashley DM
PLoS One; 2009; 4(2):e4482. PubMed ID: 19221586
[TBL] [Abstract] [Full Text] [Related]
11. Valproic acid blocks adhesion of renal cell carcinoma cells to endothelium and extracellular matrix.
Jones J; Juengel E; Mickuckyte A; Hudak L; Wedel S; Jonas D; Hintereder G; Blaheta RA
J Cell Mol Med; 2009 Aug; 13(8B):2342-2352. PubMed ID: 19067765
[TBL] [Abstract] [Full Text] [Related]
12. Predicting disease progression after nephrectomy for localized renal cell carcinoma: the utility of prognostic models and molecular biomarkers.
Crispen PL; Boorjian SA; Lohse CM; Leibovich BC; Kwon ED
Cancer; 2008 Aug; 113(3):450-60. PubMed ID: 18523999
[TBL] [Abstract] [Full Text] [Related]
13. Inhibitors of histone deacetylases as potential therapeutic tools for high-risk embryonal tumors of the nervous system of childhood.
Furchert SE; Lanvers-Kaminsky C; Juürgens H; Jung M; Loidl A; Frühwald MC
Int J Cancer; 2007 Apr; 120(8):1787-94. PubMed ID: 17230517
[TBL] [Abstract] [Full Text] [Related]
14. B7-H4 expression in renal cell carcinoma and tumor vasculature: associations with cancer progression and survival.
Krambeck AE; Thompson RH; Dong H; Lohse CM; Park ES; Kuntz SM; Leibovich BC; Blute ML; Cheville JC; Kwon ED
Proc Natl Acad Sci U S A; 2006 Jul; 103(27):10391-10396. PubMed ID: 16798883
[TBL] [Abstract] [Full Text] [Related]
15. Differential profiling analysis of proteins involved in anti-proliferative effect of interferon-alpha on renal cell carcinoma cell lines by protein biochip technology.
Nakamura K; Yoshikawa K; Yamada Y; Saga S; Aoki S; Taki T; Tobiume M; Shimazui T; Akaza H; Honda N
Int J Oncol; 2006 Apr; 28(4):965-70. PubMed ID: 16525647
[TBL] [Abstract] [Full Text] [Related]
16. Evaluation of the antitumor efficacy, pharmacokinetics, and pharmacodynamics of the histone deacetylase inhibitor depsipeptide in childhood cancer models in vivo.
Graham C; Tucker C; Creech J; Favours E; Billups CA; Liu T; Fouladi M; Freeman BB; Stewart CF; Houghton PJ
Clin Cancer Res; 2006 Jan; 12(1):223-34. PubMed ID: 16397046
[TBL] [Abstract] [Full Text] [Related]
